Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D for Doxorubicin-Induced Cardiotoxicity in Breast Cancer
NCT04166253Phase 2Completed
- Sponsor
- Damanhour University
- Start
- Sep 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alfacalcidol in Cardiotoxicity, sponsored by Damanhour University. Started Sep 2019; status: completed.
02
Drugs
alfacalcidol
03
Conditions
Cardiotoxicity
Beyond the preview
Go deeper on NCT04166253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04166253.